GENAERA CORP

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$7.7M

197 transactions

Summary

GENAERA CORP is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $6.4MSales: $1.3M15 insiders

Date	Insider	Type	Value
2009-06-05	Xmark Opportunity Partners, LLC	Sell	$427K
2008-06-20	Kaye Mitchell D	Buy	$31K
2008-06-20	Xmark Opportunity Partners, LLC	Buy	$31K
2008-06-18	Kaye Mitchell D	Buy	$21K
2008-06-19	Kaye Mitchell D	Buy	$21K
2008-06-19	Xmark Opportunity Partners, LLC	Buy	$21K
2009-06-29	Xmark Opportunity Partners, LLC	Sell	$4K
2008-12-24	Xmark Opportunity Partners, LLC	J	$0
2008-12-24	Kaye Mitchell D	J	$0
2008-08-13	ECOCK R FRANK	A	$0
2008-08-13	HOROVITZ ZOLA P	A	$0
2008-08-13	IMASOGIE OSAGIE O	A	$0
2008-08-13	Kaye Mitchell D	A	$0
2008-08-13	SHAPIRO ROBERT F	A	$0
2008-08-13	Wotton Paul K	A	$0
2008-08-11	ARMSTRONG JOHN L JR(President and CEO)	A	$0
2008-08-11	Gast Michael J(EVP & Chief Medical Officer)	A	$0
2008-08-11	Kelly Leanne M.(SVP & Chief Financial Officer)	A	$0
2008-08-11	Wolfe Henry R(EVP & Chief Scientific Officer)	A	$0
2008-06-26	Wotton Paul K	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

GENAERA CORP — Contributions, Lobbying & Contracts | Poliscope